发布求助
文献互助 智能选刊 最新文献

B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE最新文献

筛选
英文 中文
Dose-response Analyses of Treprostinil Inhalation Powder in PAH and Its Effect on 6MWD 曲前列氨酯吸入粉剂对多环芳烃的量效分析及对6MWD的影响
B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3783
K. El-Kersh, G. Ramani, M. Eggert, H. Palevsky, C. Deng, C. Thrasher, L. Spikes
{"title":"Dose-response Analyses of Treprostinil Inhalation Powder in PAH and Its Effect on 6MWD","authors":"K. El-Kersh, G. Ramani, M. Eggert, H. Palevsky, C. Deng, C. Thrasher, L. Spikes","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3783","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3783","url":null,"abstract":"","PeriodicalId":137806,"journal":{"name":"B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125573217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Phase I Clinical Trial Assessing the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of NTP42:KVA4, a Novel Thromboxane Receptor Antagonist, in Healthy Subjects 一项评估健康受试者新型血栓素受体拮抗剂NTP42:KVA4的安全性、耐受性、药代动力学和药效学的I期临床试验
B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3780
B. Kinsella, H. Reid, E. Mulvaney, M. Boyce, T. Yamamoto, M. Maginn, C. Perkins
{"title":"A Phase I Clinical Trial Assessing the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of NTP42:KVA4, a Novel Thromboxane Receptor Antagonist, in Healthy Subjects","authors":"B. Kinsella, H. Reid, E. Mulvaney, M. Boyce, T. Yamamoto, M. Maginn, C. Perkins","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3780","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3780","url":null,"abstract":"","PeriodicalId":137806,"journal":{"name":"B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122909170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treprostinil Palmitil Hydrolysis Is Facilitated by Lung Esterases 肺酯酶促进棕榈氨苄酯水解
B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3786
T.L. Nguyen, C. Chang, D. Chun, Z. Li, V. Malinin, W. Perkins, V. Viramontes, J. Zhou, M. Corboz
{"title":"Treprostinil Palmitil Hydrolysis Is Facilitated by Lung Esterases","authors":"T.L. Nguyen, C. Chang, D. Chun, Z. Li, V. Malinin, W. Perkins, V. Viramontes, J. Zhou, M. Corboz","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3786","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3786","url":null,"abstract":"","PeriodicalId":137806,"journal":{"name":"B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE","volume":"69 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114207642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extended Pulmonary Retention of Inhaled Liposomal Treprostinil (l606) Correlated With Pharmacodynamics and Plasma Pharmacokinetics 吸入treprostiil脂质体延长肺潴留与药效学和血浆药动学的相关性
B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3782
P. Kan, K. Chen
{"title":"Extended Pulmonary Retention of Inhaled Liposomal Treprostinil (l606) Correlated With Pharmacodynamics and Plasma Pharmacokinetics","authors":"P. Kan, K. Chen","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3782","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3782","url":null,"abstract":"","PeriodicalId":137806,"journal":{"name":"B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134601891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Longitudinal Use of Midodrine to Optimize Pulmonary Hypertension Therapies 纵向应用Midodrine优化肺动脉高压治疗
B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3771
Z. Safdar, N. Giese, M. Sarah, A. Mulumudi, C. Tanabe, E. Graviss, D. Nguyen
{"title":"Longitudinal Use of Midodrine to Optimize Pulmonary Hypertension Therapies","authors":"Z. Safdar, N. Giese, M. Sarah, A. Mulumudi, C. Tanabe, E. Graviss, D. Nguyen","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3771","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3771","url":null,"abstract":"","PeriodicalId":137806,"journal":{"name":"B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128523048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A First-in-Human Single/Multiple Ascending Dose Study of ANPA-0073, a Novel Small Molecule G-protein Biased Apelin Receptor Agonist, in Healthy Volunteers 新型小分子g蛋白偏性Apelin受体激动剂ANPA-0073在健康志愿者中的首次人体单次/多次递增剂量研究
B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3775
M. Bach, S. Shi, J. Zhang, E. Parsley, C. Argent, C. Guan, M. Pelayo, L. Ibarra, S. Lim
{"title":"A First-in-Human Single/Multiple Ascending Dose Study of ANPA-0073, a Novel Small Molecule G-protein Biased Apelin Receptor Agonist, in Healthy Volunteers","authors":"M. Bach, S. Shi, J. Zhang, E. Parsley, C. Argent, C. Guan, M. Pelayo, L. Ibarra, S. Lim","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3775","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3775","url":null,"abstract":"","PeriodicalId":137806,"journal":{"name":"B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130187219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of Long-term Oxygen Therapy in Patients With Pulmonary Hypertension in Spain 西班牙肺动脉高压患者长期氧疗的应用
B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3773
I. Blanco, R. Torres-Castro, R. Aguilar, R. Lopez-reyes, A. Martínez-Meñaca, J.A. Tenes Mayen, C. Martín-Ontiyuelo, M. Álvarez-Barredo, P. Escribano-Subías, J. Barberà
{"title":"Use of Long-term Oxygen Therapy in Patients With Pulmonary Hypertension in Spain","authors":"I. Blanco, R. Torres-Castro, R. Aguilar, R. Lopez-reyes, A. Martínez-Meñaca, J.A. Tenes Mayen, C. Martín-Ontiyuelo, M. Álvarez-Barredo, P. Escribano-Subías, J. Barberà","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3773","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3773","url":null,"abstract":"","PeriodicalId":137806,"journal":{"name":"B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE","volume":"132 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121545062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tolerability of Treprostinil Dry-powdered Inhaler in Patients With Pulmonary Hypertension Related to Fibrosing Interstitial Lung Disease at a Large Respiratory Referral Center 在一个大型呼吸转诊中心，曲前列地尼干粉状吸入器对纤维化间质性肺病相关肺动脉高压患者的耐受性
B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3774
M. Dalabih, A. Randall, J. Rice, D. Kim, S. Sunder, A. Freeman, V. Pillitteri, T. Lahm, M. P. George
{"title":"Tolerability of Treprostinil Dry-powdered Inhaler in Patients With Pulmonary Hypertension Related to Fibrosing Interstitial Lung Disease at a Large Respiratory Referral Center","authors":"M. Dalabih, A. Randall, J. Rice, D. Kim, S. Sunder, A. Freeman, V. Pillitteri, T. Lahm, M. P. George","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3774","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3774","url":null,"abstract":"","PeriodicalId":137806,"journal":{"name":"B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE","volume":"62 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133533621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ELEVATE 2: Baseline Demographic Characteristics From the Phase IIB Study of the Efficacy and Safety of Two Doses of Rodatristat Ethyl When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension ELEVATE 2:加入标准护理方案治疗肺动脉高压时，两剂量Rodatristat Ethyl的有效性和安全性的IIB期研究的基线人口统计学特征
B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3781
A. Skride, J. Feldman, O. Shlobin, S. Sahay, J. Denning, W. Kamau-Kelley, G. Gareth, R. Jones, R. Grewal, S. Hoffman, H. Lazarus, O. Sitbon
{"title":"ELEVATE 2: Baseline Demographic Characteristics From the Phase IIB Study of the Efficacy and Safety of Two Doses of Rodatristat Ethyl When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension","authors":"A. Skride, J. Feldman, O. Shlobin, S. Sahay, J. Denning, W. Kamau-Kelley, G. Gareth, R. Jones, R. Grewal, S. Hoffman, H. Lazarus, O. Sitbon","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3781","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3781","url":null,"abstract":"","PeriodicalId":137806,"journal":{"name":"B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE","volume":"40 13","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133041990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Endothelin Receptor Antagonists (ERA) and Integrase Inhibitors: Competition or Cooperation? 内皮素受体拮抗剂(ERA)和整合酶抑制剂:竞争还是合作?
B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3772
João Ferreira da Silva Filho, M.G. Gurgel Junior, C. Fernandes, C. Jardim
{"title":"Endothelin Receptor Antagonists (ERA) and Integrase Inhibitors: Competition or Cooperation?","authors":"João Ferreira da Silva Filho, M.G. Gurgel Junior, C. Fernandes, C. Jardim","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3772","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3772","url":null,"abstract":"","PeriodicalId":137806,"journal":{"name":"B59. BREAKING BAD: NEW DRUGS AND FORMULATIONS FOR PULMONARY HYPERTENSION AND RV FAILURE","volume":"31 11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125703403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信